VSVictor Costa de Souza

Victor Costa de Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victor Costa de Souza has a total of 287 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Venezuelan Equine Encephalitis Virus, Amazonas, Brazil, 2025

    by Franklin Simões de Santana Filho, Marcelo Ferreira dos Santos, Victor Costa de Souza, Valdinete Alves Do Nascimento, Maria Do Perpétuo Socorro Lopes dos Santos, Gian Pierre Hernandez Medina, Klaus Estivens Lima Salazar, Jhamylee Evellyn Sanchez Mendez, Elizabeth Andreia da Silva Brito Fajardo, Luis Castelo Branco de Oliveira, et al.

    We report the first detection of Venezuelan Equine Encephalitis Virus (VEEV) in residents of Tabatinga, Amazonas, Brazil, a tri-border region with Colombia and Peru. Brazilian and Peruvian sequences clustered together, suggesting potential cross-border transmission. Our findings identify VEEV as an underrecognized etiology of acute febrile illness in the Brazilian Amazon.


  • Open Access

    Emergence of a novel reassortant Oropouche virus drives persistent human outbreaks in the Brazilian Amazon region from 2022 to 2024

    by Felipe Gomes Naveca, Tatiana Amaral Pires de Almeida, Victor Souza, Valdinete Nascimento, Dejanane Silva, Fernanda Nascimento, Matilde Mejía, Yasmin Silva de Oliveira, Luisa Rocha, Natana Xavier, et al.

    The Brazilian western Amazon region is currently experiencing its largest laboratory confirmed Oropouche virus (OROV) outbreak, with nearly 6,000 reported cases in the states of Amazonas (AM), Acre (AC), Rondônia (RO), and Roraima (RR), between August 2022 and March 2024. Here, we sequenced and analyzed 382 full-length OROV genomes from human samples collected between 2022 and 2024 from all four states, aiming to trace the origin and genetic evolution of OROV leading to the current outbreak. Genomic analyses revealed that the recent upsurge of OROV cases in the Brazilian Amazon region coincides with the emergence of a novel reassortant viral lineage containing the M segment of viruses detected in the eastern Amazon region from 2009 to 2018 and the L and S segments of viruses detected in Peru, Colombia, and Ecuador from 2008 to 2021. The novel reassortant OROV lineage likely emerged in the Central region of the AM state between 2010 and 2014 and displayed a long-range silent dispersion during the second half of the 2010s. The 2022-2024 OROV epidemic was spatially segregated into three major subpopulations located in RR, AMACRO (a bordering region between AC, RO, and AM-Southern region), and AM-Central (which includes the Amazonas’ capital, Manaus) regions. The peak of OROV transmissions in all regions occurred during the rainy season in the Amazon basin. Furthermore, our phylodynamics reconstructions showed that OROV spread was driven mainly by short-range (< 2 km) movements, with an average dispersal rate ≤ 1.2 km/day, consistent with the pattern of an active flight of infected vectors. Nevertheless, a substantial proportion (22%) of long-range (> 10 km) OROV migrations were also detected, consistent with viral dispersion via human activities. Our data provides an unprecedented view of the real-time spread and evolution of a neglected emergent human pathogen. Moreover, our results emphasize the need for widespread, long-term genomic surveillance to better understand the real burden of OROV within and beyond the Amazon region.


  • Open Access

    In silico analysis of non-structural protein 12 sequences from SARS-COV-2 found in Manaus, Amazonas, Brazil, reveals mutations linked to higher transmissibility

    by Fernando B. Zanchi, Gabriel Eduardo M. Ferreira, Luis André M. Mariúba, Juliane C. Glória, Valdinete A. Do Nascimento, Victor C. DE Souza, André DE Lima G. Corado, Fernanda O. Do Nascimento, Ágatha Kélly A. DA Costa, Débora Camila G. Duarte, et al.

    The disease coronavirus COVID-19 has been the cause of millions of deaths worldwide. Among the proteins of SARS-CoV-2, non-structural protein 12 (NSP12) plays a key role during COVID infection and is part of the RNA-dependent RNA polymerase complex. The monitoring of NSP12 polymorphisms is extremely important for the design of new antiviral drugs and monitoring of viral evolution. This study analyzed the NSP12 mutations detected in circulating SARS-CoV-2 during the years 2020 to 2022 in the population of the city of Manaus, Amazonas, Brazil. The most frequent mutations found were P323L and G671S. Reports in the literature indicate that these mutations are related to transmissibility efficiency, which may have contributed to the extremely high numbers of cases in this location. In addition, two mutations described here (E796D and R914K) are close and have RMSD that is similar to the mutations M794V and N911K, which have been described in the literature as influential on the performance of the NSP12 enzyme. These data demonstrate the need to monitor the emergence of new mutations in NSP12 in order to better understand their consequences for the treatments currently used and in the design of new drugs.


  • Open Access

    Reemergence of Dengue Virus Serotype 3, Brazil, 2023

    by Felipe Gomes Naveca, Gilberto A Santiago, Rodrigo Melo Maito, Cátia Alexandra Ribeiro Meneses, Valdinete Alves Do Nascimento, Victor Costa de Souza, Fernanda Oliveira Do Nascimento, Dejanane Silva, Matilde Mejía, Luciana Gonçalves, et al.

    In 2023, three autochthonous DENV-3 cases were detected in Roraima and one imported case in Paraná, fifteen years after the last DENV-3 outbreak in Brazil. Phylogenetic analyses confirmed all belonging to a new Asian lineage recently introduced in the Americas, raising concerns about future large dengue outbreaks in this region.


  • Open Access

    Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in Amazonas, a Brazilian setting with high levels of hybrid immunity

    by Ighor Arantes, Gonzalo Bello, Valdinete Nascimento, Victor Souza, Arlesson da Silva, Dejanane Silva, Fernanda Nascimento, Matilde Mejía, Maria Júlia Brandão, Luciana Gonçalves, et al.

    The SARS-CoV-2 variants of concern (VOCs) Delta and Omicron spread globally during mid and late 2021, respectively, with variable impact according to the immune population landscape. In this study, we compare the dissemination dynamics of these VOCs in the Amazonas state, one of Brazil’s most heavily affected regions. We sequenced the virus genome from 4,128 patients collected in Amazonas between July 1st, 2021 and January 31st, 2022 and investigated the lineage replacement dynamics using a phylodynamic approach. The VOCs Delta and Omicron displayed similar patterns of phylogeographic spread but significantly different epidemic dynamics. The Delta and Omicron epidemics were fueled by multiple introduction events, followed by the successful establishment of a few local transmission lineages of considerable size that mainly arose in the Capital, Manaus. The VOC Omicron spread and became dominant much faster than the VOC Delta. We estimate that under the same epidemiological conditions, the average Re of Omicron was ∼3.3 times higher than that of Delta and the average Re of the Delta was ∼1.3 times higher than that of Gamma. Furthermore, the gradual replacement of Gamma by Delta occurred without an upsurge of COVID-19 cases, while the rise of Omicron fueled a sharp increase in SARS-CoV-2 infection. The Omicron wave displayed a shorter duration and a clear decoupling between the number of SARS-CoV-2 cases and deaths compared with previous (B.1.* and Gamma) waves in the Amazonas state. These findings suggest that the high level of hybrid immunity (infection plus vaccination) acquired by the Amazonian population by mid-2021 was able to limit the spread of the VOC Delta and was also probably crucial to curb the number of severe cases, although not the number of VOC Omicron new infections.

  • Open Access

    Structural analysis of SARS-Cov-2 nonstructural protein 1 polymorphisms found in the Brazilian Amazon

    by Fernando Berton Zanchi, Luis André Mariúba, Valdinete Nascimento, Victor Souza, André Corado, Fernanda Nascimento, Ágatha Kelly Costa, Débora Duarte, George Silva, Matilde Mejía, et al.

    The coronavirus disease COVID-19 has been the cause of millions of deaths worldwide. Among the SARS-CoV-2 proteins, the non-structural protein 1 (NSP1) has great importance during the virus infection process and is present in both alpha and beta-CoVs. Therefore, monitoring of NSP1 polymorphisms is crucial in order to understand their role during infection and virus-induced pathogenicity. Herein, we analyzed how mutations detected in the circulating SARS-CoV-2 in the population of the city of Manaus, Amazonas state, Brazil could modify the tertiary structure of the NSP1 protein. Three mutations were detected in the SARS-CoV-2 NSP1 gene: deletion of the amino acids KSF from positions 141 to 143 (delKSF), SARS-CoV-2, lineage B.1.195; and two substitutions, R29H and R43C, SARS-CoV-2 lineage B.1.1.28 and B.1.1.33, respectively. The delKSF was found in 47 samples, whereas R29H and R43C were found in two samples, one for each mutation. The NSP1 structures carrying the mutations R43C and R29H on the N-terminal portion (e.g. residues 10 to 127) showed minor backbone divergence compared to the Wuhan model. However, the NSP1 C-terminal region (residues 145 to 180) was severely affected in the delKSF and R29H mutants. The intermediate variable region (residues 144 to 148) leads to changes in the C-terminal region, particularly in the delKSF structure. New investigations must be carried out to analyze how these changes affect NSP1 activity during the infection. Our results reinforce the need for continuous genomic surveillance of SARS-CoV-2 to better understand virus evolution and assess the potential impact of the viral mutations on the approved vaccines and future therapies.


  • Open Access

    Spread of Gamma (P.1) sub-lineages carrying Spike mutations close to the furin cleavage site and deletions in the N-terminal domain drives ongoing transmission of SARS-CoV-2 in Amazonas, Brazil

    by Felipe Gomes Naveca, Valdinete Nascimento, Victor Souza, André de Lima Corado, Fernanda Nascimento, George Silva, Matilde Mejía, Maria Júlia Brandão, Ágatha Costa, Débora Duarte, et al.

    Summary: The Amazonas was one of the most heavily affected Brazilian states by the COVID-19 epidemic. Despite a large number of infected people, particularly during the second wave associated with the spread of the Variant of Concern (VOC) Gamma (lineage P.1), SARS-CoV-2 continues to circulate in the Amazonas. To understand how SARS-CoV-2 persisted in a human population with a high immunity barrier, we generated 1,188 SARS-CoV-2 whole-genome sequences from individuals diagnosed in the Amazonas state from 1st January to 6th July 2021, of which 38 were vaccine breakthrough infections. Our study reveals a sharp increase in the relative prevalence of Gamma plus (P.1+) variants, designated as Pango Lineages P.1.3 to P.1.6, harboring two types of additional Spike changes: deletions in the N-terminal (NTD) domain (particularly Δ 144 or Δ 141-144) associated with resistance to anti-NTD neutralizing antibodies or mutations at the S1/S2 junction (N679K or P681H) that probably enhance the binding affinity to the furin cleavage site, as suggested by our molecular dynamics simulations. As lineages P.1.4 (S:N679K) and P.1.6 (S:P681H) expanded (Re > 1) from March to July 2021, the lineage P.1 declined (Re < 1) and the median Ct value of SARS-CoV-2 positive cases in Amazonas significantly decreases. Still, we found no overrepresentation of P.1+ variants among breakthrough cases of fully vaccinated patients (71%) in comparison to unvaccinated individuals (93%). This evidence supports that the ongoing endemic transmission of SARS-CoV-2 in the Amazonas is driven by the spread of new local Gamma/P.1 sub-lineages that are more transmissible, although not more efficient to evade vaccine-elicited immunity than the parental VOC. Finally, as SARS-CoV-2 continues to spread in human populations with a declining density of susceptible hosts, the risk of selecting new variants with higher infectivity are expected to increase.


  • Open Access

    Three SARS-CoV-2 reinfection cases by the new Variant of Concern (VOC) P.1/501Y.V3

    by Felipe Naveca, Cristiano da Costa, Valdinete Nascimento, Victor Souza, André Corado, Fernanda Nascimento, Ágatha Costa, Débora Duarte, George Silva, Matilde Mejía, et al.

    The SARS-CoV-2 lineage B.1.1.28 has been evolving in Brazil since February 2020 giving origin to multiple local clades including the new Variant of Concern (VOC) designated P.1 or 501Y.V3. The recent emergence of sub-lineages with convergent mutations in the spike (S) protein raises concern about the potential impact on viral infectivity and immune escape. We describe here the first three confirmed SARS-CoV-2 reinfections cases with the new VOC P.1 in residents of the Amazonas state, Brazil. Three female patients, 29, 40, and 50-year-old, were RT-PCR confirmed for SARS-CoV-2 on two occasions, with at least 92 days apart. Next-generation sequencing and phylogenetic analysis were conducted to precisely access the SARS-CoV-2 lineages of each infection event. SARS-CoV-2 genomic analysis confirmed three cases of reinfections caused by the VOC P.1 in patients that were primo-infected by distinct viral lineages 3–9 months earlier. Case 1 (29-year-old) was positive on March 24, 2020 (lineage B.1.195) and then on December 30, 2020 (lineage P.1); case 2 (50-year-old) was positive on October 19, 2020 (lineage B.1.1.33) and on January 19, 2021 (lineage P.1); case 3 (40-year-old) was positive on April 22, 2020 (lineage B.1.195) and on January 29, 2021 (lineage P.1). The three patients displayed low mean Ct values (< 22) at nasopharyngeal samples and reported less severe illness during reinfection. The present study provides the first evidence of the new VOC P.1 causing multiple reinfections during the second epidemic peak in the Amazonas state. Our findings suggest that reinfected individuals may have been infectious. Although immune responses induced by natural infections do not necessarily prevent subsequent infections by the VOC P.1, they may still protect from severe disease.


  • Open Access

    Mayaro virus detection in the western region of Pará state, Brazil

    by Cassiano Junior Saatkamp, Luís Reginaldo Ribeiro Rodrigues, Andrew Mairom Nogueira Pereira, João Alberto Coelho, Rose Grace Brito Marques, Victor Costa de Souza, Valdinete Alves Do Nascimento, Jamille Gomes dos Santos Saatkamp, Felipe Gomes Naveca, Regina Maria Pinto de Figueiredo

    INTRODUCTION: Mayaro virus (MAYV) was found in Pará state, Brazil, in 1955. Since then, sporadic outbreaks have occurred in different regions of the country.


  • Open Access

    Oropouche virus detection in saliva and urine

    by Valdinete Alves Do Nascimento, João Hugo Abdalla Santos, Dana Cristina da Silva Monteiro, Karina Pinheiro Pessoa, Antonio José Leão Cardoso, Victor Costa de Souza, Ligia Fernandes Abdalla, Felipe Gomes Naveca

    An infection with OROV can result in an acute febrile and exanthematous illness, with symptoms frequently similar to other viral infections such as dengue. Oropouche fever cases were reported in several Brazilian states, including Amazonas, Acre, Bahia, Pará and Mato Grosso, as well as in other South American countries.2,3,4,5,6,7,8,9,10